DekaBank Deutsche Girozentrale’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-950	Closed	-$83K	–	1076
2016 Q1	$83K	Buy	950 +35	+4%	+$3.5K	﹤0.01%	990
2015 Q4	$185K	Sell	915 -5	-0.5%	-$998	﹤0.01%	878
2015 Q3	$137K	Buy	920 +45	+5%	+$33K	﹤0.01%	930
2015 Q2	$830K	Buy	875 +155	+22%	+$127K	0.01%	597
2015 Q1	$528K	Buy	+720	New	+$541K	0.01%	702

Other funds holding TTPH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

DekaBank Deutsche Girozentrale's TTPH Position: Q2 2016 in Review

DekaBank Deutsche Girozentrale sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2016, closing a stake of 950 shares — an estimated $83K sold.

DekaBank Deutsche Girozentrale first reported a position in TTPH in Q1 2015 and held it in 5 quarters. The position peaked at $830K in Q2 2015. 91 funds tracked by Wall St. Rank hold TTPH as of Q2 2016.

DekaBank Deutsche Girozentrale reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 950 Tetraphase Pharmaceuticals, Inc. shares in Q2 2016, an estimated $83K.
DekaBank Deutsche Girozentrale first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2015 and held it in 5 quarters.
DekaBank Deutsche Girozentrale's Tetraphase Pharmaceuticals, Inc. position peaked at $830K in Q2 2015.
91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2016.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2016, filed 4 Aug 2016.